Involvement of ZIP/p62 in the regulation of PPARα transcriptional activity by p38-MAPK

被引:12
|
作者
Diradourian, Claire [1 ,2 ]
Le May, Cedric [1 ,2 ]
Cauezac, Michele [1 ,2 ]
Girard, Jean [1 ,2 ]
Burnol, Anne-Francoise [1 ,2 ]
Pegorier, Jean-Paul [1 ,2 ]
机构
[1] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France
[2] INSERM, U567, Paris, France
关键词
PPAR alpha; p38-MAPK; ZIP/p62; L-CPTI; phosphorylation; anisomycin; reporter gene; co-immunoprecipitation; siRNA; hepatoma cell;
D O I
10.1016/j.bbalip.2008.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peroxisome proliferator-activated receptor alpha (PPAR alpha) belongs to the nuclear receptor family and plays a central role in the regulation of lipid metabolism, glucose homeostasis and inflammatory processes. In addition to its ligand-induced activation, PPAR alpha is regulated by phosphorylation via ERK-MAPK, PKA and PKC. In this study we examined the effect of p38-MAPK on PPAR alpha transcriptional activity. In COS-7 cells, anisomycin, a p38 activator, induced a dose-dependent phosphorylation of PPAR alpha and a 50% inhibition of its transcriptional activity. In H4IIE hepatoma cells, anisomycin-induced p38 phosphorylation decreased both endogenous and PPAR alpha ligand-enhanced L-CPTI and ACO gene expression. Interestingly, PPAR alpha/p38 interaction required the molecular adapter ZIP/p62. Reducing ZIP/p62 expression by siRNA, partially reversed the inhibitory effect of anisomycin on L-CPTI gene expression. In conclusion, we showed that p38 activation induced PPAR alpha phosphorylation and inhibition of its transcriptional activity through a trimeric interaction between p38-MAPK, ZIP/p62 and PPAR alpha. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 50 条
  • [21] Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease
    Clark, James E.
    Sarafraz, Negin
    Marber, Michael S.
    PHARMACOLOGY & THERAPEUTICS, 2007, 116 (02) : 192 - 206
  • [22] Autophagic Regulation of p62 is Critical for Cancer Therapy
    Islam, Md. Ariful
    Sooro, Mopa Alina
    Zhang, Pinghu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [23] The cytotoxic prodigiosin induces phosphorylation of p38-MAPK but not of SAPK/JNK
    Montaner, B
    Pérez-Tomás, R
    TOXICOLOGY LETTERS, 2002, 129 (1-2) : 93 - 98
  • [24] Calcium paradox induces apoptosis in the isolated perfused Rana ridibunda heart: involvement of p38-MAPK and calpain
    Aggeli, Ioanna-Katerina
    Zacharias, Triantafyllos
    Papapavlou, Georgia
    Gaitanaki, Catherine
    Beis, Isidoros
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2013, 91 (12) : 1095 - 1106
  • [25] Involvement of p38 MAPK in the Anticancer Activity of Cultivated Cordyceps militaris
    Chou, Shang-Min
    Lai, Wan-Jung
    Hong, Tzuwen
    Tsai, Sheng-Hong
    Chen, Yen-Hsun
    Kao, Cheng-Hsiang
    Chu, Richard
    Shen, Tang-Long
    Li, Tsai-Kun
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2015, 43 (05): : 1043 - 1057
  • [26] Regulation of autophagy by p38α MAPK
    Webber, Jemma L.
    AUTOPHAGY, 2010, 6 (02) : 292 - +
  • [27] Cardioprotection by carbon monoxide (CO) in the isolated mouse heart is dependant upon P38-MAPK activity
    Clark, J. E.
    Marber, M. S.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S52 - S52
  • [28] p38-MAPK induced dephosphorylation of α-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity
    Vahebi, Susan
    Ota, Asuka
    Li, Manxiang
    Warren, Chad M.
    de Tombe, Pieter P.
    Wang, Yibin
    Solaro, R. John
    CIRCULATION RESEARCH, 2007, 100 (03) : 408 - 415
  • [29] Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1
    Kawai, Kayoko
    Saito, Akiko
    Sudo, Tatsuhiko
    Osada, Hiroyuki
    JOURNAL OF BIOCHEMISTRY, 2008, 143 (06): : 765 - 772
  • [30] Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation
    Antoon, James W.
    Bratton, Melyssa R.
    Guillot, Lori M.
    Wadsworth, Scott
    Salvo, Virgilio A.
    Burow, Matthew E.
    CANCER BIOLOGY & THERAPY, 2012, 13 (11) : 1026 - 1033